ALTERITY THERAPEUTICS LTD - SPONSORED ADS (ATHE)

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / SPONSORED ADS
Total 13F shares
77,979
Share change
-15,983
Total reported value
$140,908
Price per share
$1.81
Number of holders
10
Value change
-$37,731
Number of buys
1
Number of sells
3

Institutional Holders of ALTERITY THERAPEUTICS LTD - SPONSORED ADS (ATHE) as of Q2 2024

As of 30 Jun 2024 ALTERITY THERAPEUTICS LTD - SPONSORED ADS (ATHE) had 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 77,979 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Twin Lakes Capital Management, LLC, Providence Capital Advisors, LLC, OSAIC HOLDINGS, INC., Sugarloaf Wealth Management, LLC, CoreCap Advisors, LLC, Steward Partners Investment Advisory, LLC, Coppell Advisory Solutions LLC, and UBS Group AG.
This table shows 10 institutional shareholders of the security as of 30 Jun 2024.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.